Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles

被引:83
作者
Cassidy, Pamela B.
Edes, Kornelia
Nelson, Chad C.
Parsawar, Krishna
Fitzpatrick, F. A.
Moos, Philip J.
机构
[1] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA
[2] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA
[3] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA
[4] Univ Utah, Mass Spectrometry & Proteom Core Facil, Salt Lake City, UT 84112 USA
关键词
D O I
10.1093/carcin/bgl111
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous studies demonstrate that the covalent modification of thioredoxin reductase (TrxR) by both endogenous and exogenous electrophiles results in disruption of the conformation of the tumor suppressor protein p53. Here we report that the loss of normal cellular TrxR enzymatic activity by electrophilic modification or deletion of the C-terminal catalytic selenocysteine residue has functional consequences that are distinct from those resulting from depletion of TrxR protein in human RKO colon cancer cells. A thorough kinetic analysis was performed on purified TrxR in order to characterize the mechanism of its inhibition by electrophiles. Furthermore, electrospray mass spectrometry confirmed the alkylation of TrxR by lipid electrophiles and liquid chromatography-mass spectrometry/mass spectrometry identified the C-terminus as one target for alkylation. Then the consequences of TrxR modification by electrophiles on p53 conformation, transactivation and apoptosis were compared and contrasted with the effects of depletion of TrxR protein by treatment of cells with small interfering RNA directed against TrxR1. We found that cells depleted of TrxR were actually less sensitive to electrophile-induced disruption of p53 conformation and apoptosis than were cells expressing normal levels of TrxR. When RKO cells depleted of wild-type TrxR were transfected with C-terminal mutants of TrxR lacking the catalytic selenocysteine, p53 was found to be conformationally deranged, similar to cells treated with electrophiles. These results lead us to conclude that C-terminal modification of TrxR is both necessary and sufficient for the disruption of p53 and for the induction of apoptosis. Endogenous lipid electrophiles have been our primary focus; however, metabolic activation of hormones can generate endogenous mutagens, and we demonstrate that estrone-quinone attenuates p53 function in human MCF7 cells.
引用
收藏
页码:2538 / 2549
页数:12
相关论文
共 60 条
[1]   SUICIDE ENZYME INACTIVATORS [J].
ABELES, RH ;
MAYCOCK, AL .
ACCOUNTS OF CHEMICAL RESEARCH, 1976, 9 (09) :313-319
[2]   BASIC LOCAL ALIGNMENT SEARCH TOOL [J].
ALTSCHUL, SF ;
GISH, W ;
MILLER, W ;
MYERS, EW ;
LIPMAN, DJ .
JOURNAL OF MOLECULAR BIOLOGY, 1990, 215 (03) :403-410
[3]   Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine [J].
Anestål, K ;
Arnér, ESJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (18) :15966-15972
[4]   Physiological functions of thioredoxin and thioredoxin reductase [J].
Arnér, ESJ ;
Holmgren, A .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (20) :6102-6109
[5]  
Arnér ESJ, 2002, METHOD ENZYMOL, V347, P226
[6]   1-CHLORO-2,4-DINITROBENZENE IS AN IRREVERSIBLE INHIBITOR OF HUMAN THIOREDOXIN REDUCTASE - LOSS OF THIOREDOXIN DISULFIDE REDUCTASE-ACTIVITY IS ACCOMPANIED BY A LARGE INCREASE IN NADPH OXIDASE ACTIVITY [J].
ARNER, ESJ ;
BJORNSTEDT, M ;
HOLMGREN, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (08) :3479-3482
[7]   The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli [J].
Arscott, LD ;
Gromer, S ;
Schirmer, RH ;
Becker, K ;
Williams, CH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3621-3626
[8]   Thioredoxin reductase as a pathophysiological factor and drug target [J].
Becker, K ;
Gromer, S ;
Schirmer, RH ;
Müller, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (20) :6118-6125
[9]   Human thioredoxin reductase is efficiently inhibited by (2,2′:6′,2"-terpyridine)platinum(II) complexes.: Possible implications for a novel antitumor strategy [J].
Becker, K ;
Herold-Mende, C ;
Park, JJ ;
Lowe, G ;
Schirmer, RH .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (17) :2784-2792
[10]   Biosynthesis of 15-deoxy-Δ12,14-PGJ2 and the litigation of PPARγ [J].
Bell-Parikh, LC ;
Ide, T ;
Lawson, JA ;
McNamara, P ;
Reilly, M ;
FitzGerald, GA .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (06) :945-955